ZURICH, July 2 (Reuters) - The Swiss blue-chip SMI was seen opening 0.3 percent lower at 8,589 points on Monday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks.
Billionaire investor Daniel Loeb on Sunday stepped up pressure on the food group, in a letter that urged its board to be “sharper,” “bolder” and “faster” in spinning off businesses and untangling its complex management structure.
The shares were seen rising 0.5 percent, according to premarket indicators.
For more click
The Swiss drugmaker said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.
For more click
The Swiss asset manager told employees it was preparing for a “worst case” Brexit scenario in which Britain gives up full access to the single market and customs union with the European Union, the Financial Times reported on Monday, citing an internal company email.
CEO Urs Schaeppi said his phone company has prepared for competition from France’s Iliad in the Italian mobile phone market, according to an interview in Finanz und Wirtschaft.
The Swiss drugmaker’s Chairman Joerg Reinhardt expects Alcon to be valued at between $20 billion and $30 billion when the opthalmic devices unit is spun off to shareholders next year, he said in an interview with Finanz und Wirtschaft.
* LafargeHolcim said it canceled its liquidity enhancement agreement on Euronext Paris
* Glarner Kantonalbank said a local court had rejected its liability action against former managers, prompting the regional bank to review its options including an appeal to the Swiss high court
* DKSH Holding said it entered a regional partnership with Coty Professional Beauty in Singapore and Malaysia
* Implenia said it boosted a credit facility by 150 million Swiss francs to 800 million francs
* Syngenta said Eveline Saupper, a member of the Board of Directors of Syngenta since 2013, stepped down, replaced by former Roche manager Sophie Kornowski, who is slated to go to work for a Boston-area healthcare investment fund.
* Comet Group said Detlef Steck, president of X-Ray Systems is resigning, with Matthias Barz to become his interim replacement.
* Kuros said its commercial rollout of MagnetOs is on track in the United States and Europe, with the first sales in the United States and Britain.
Swiss May retail sales at 0715 GMT
Swiss June manufacturing PMI at 0730 GMT (Reporting by Zurich newsroom)